다이
다이오진 Stock: price and insider trades · South Korea
다이오진: what insiders have been doing
Every trade that managers of 다이오진 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. No insider at 다이오진 has published a filing in the past twelve months. The most recent one dates from 6 April 2022.
Elsewhere in the same sector, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
5 ops. · all time
Financial data
· cache
Last declaration on 6 April 2022
Declarations11 total
- 105,175 sharesKRXDART:20220405002948
- 78,944 sharesShareKRXDART:20220405002942
- 105,175 sharesKRXDART:20220404002535
- 78,944 sharesShareKRXDART:20220404002322
- 26,231 sharesShareKRXDART:20220318000507
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
11 of 11 declarations
About 다이오진
Daiojin is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX.
